DEVLIN JODI (President, Therapeutics) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/29/2025ACC: 0001415889-25-002285
Officer· President, Therapeutics
Since Aug 2023
+74.38K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
74.38K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.63K
Price / share
—
Trade value
—
% of position
60.7%
1/27/2025
17.50K→28.13K
Total
Net shares
+10.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2025 | A · Award | +10.63K | — | — | 60.7% | 17.50K | 28.13K |
| Total | +10.63K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
63.75K shares
Shares
+63.75K
Strike price
5.30
Held after
63.75K
Exercisable
—
1/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock63.75K shares | 1/27/2025 | A · Award | +63.75K | 5.30 | — | 63.75K |